Hypertension

Spironolactone May Help Hypertensive Diabetics

Jody A. Charnow March 02, 2010

Adding spironolactone to a regimen that includes maximal ACE inhibition improves renoprotection in hypertensive patients with diabetic nephropathy, data suggest.
 

BP Drug Combination May Offer Better Renoprotection

Jody A. Charnow February 17, 2010

Use of benazepril with amlodipine rather than hydrochlorothiazide is more effective at slowing CKD progression.
 

ACE Inhibitors, Angiotensin Receptor Blockers Have Heart Benefits in Hemodialysis Patients

February 16, 2010

Study finds that the drugs reduce left ventricular mass.
 

Hypertension, Fructose Intake Linked

John Schieszer January 22, 2010

Those who consume 74 grams or more of fructose daily are at higher risk than those who consume less.
 

Cocoa Can Decrease Blood Pressure, Study Shows

Jody A. Charnow January 05, 2010

Cocoa products such as dark chocolate and cocoa-containing beverages can lower blood pressure, a recent meta-analysis confirms.
 

Spironolactone Improves Renoprotection in Patients with Diabetes and Hypertension

Jody A. Charnow January 04, 2010

Adding spironolactone to a regimen that includes maximal ACE inhibition improves renoprotection in patients with diabetic nephropathy, data suggest.
 

Insurance Gaps Affect Use Blood Pressure Medications

Jody A. Charnow December 14, 2009

Hypertensive patients who experience gaps in their health insurance coverage are less likely to continue with their anti-hypertensive medications, according to researchers.
 

FDA Approves Aliskiren/Valsartan Combination Pill

Jody A. Charnow October 16, 2009

FDA has approved Valturna (aliskiren and valsartan) tablets, which the drug's maker, Novartis, of East Hanover, N.J., said is the first and only product to target two key points in the renin angiotensin aldosterone system (RAAS).
 

Hypertension: A Public Health Challenge

George L. Bakris, MD, FASN, Keith Hopkins, MD October 16, 2009

Hypertension rates are expected to rise due to a growing prevalence of obesity and other risk factors.
 

Obesity Raises Prehypertensives' Risk

Jody A. Charnow October 12, 2009

In a study, prehypertensive patients with the highest BMI had a sixfold increased risk of treated end-stage renal disease or CKD-related death.
 

NKF Live Promotion

Enter a contest to win one of three $150 American Express gift cards by signing up for the free NKF Live e-newsletter. You will receive daily news coverage of the National Kidney Foundation 2010 Spring Clinical Meetings in Orlando, Fla.

Click here to sign up today



Visit Fresenius Medical Care during the National Kidney Foundation 2010 Spring Clinical Meetings in Orlando, Fla. at Booth #407.
Visit our Conference Highlights section for news from recent meetings, including our coverage of the 2010 Genitourinary Cancers Symposium.

Your Money

Visit Your Money for the latest financial news and advice.
Stay up to date on the latest Legal Issues affecting urologists and nephrologists.
Our World Literature Review department has information on the latest nephrology and urology studies from around the world.

Renal & Urology News
E-Newsletters

Sign up today to start receiving one of three free e-newsletters from Renal & Urology News or get them all.
- eTOC (print edition preview)
- RUN Roundup
- Conference Highlights

Sample | Subscribe | Archive


Popular Topics
Acute Kidney Injury Adrenal Gland Bladder Cancer BPH Brachytherapy Cardiovascular Disease Chronic Kidney Disease CKD Diabetes Diabetes Mellitus Dialysis End-stage Renal Disease Epidemiology FSGS Hemodialysis Hypertension Hypogonadism Incontinence Kidney Cancer Kidney Disease Obesity Prostate Cancer Renal Cell Carcinoma Reproductive Medicine Transplantation